{
  "id": 7553479,
  "title": "CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th",
  "url": "https://urgent.news/2026/09/15/cytodyn-inc-to-present-at-the-life-sciences-investor-forum-on",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-15T12:35:22.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/cytodyn-inc-to-present-at-the-life-sciences-investor-forum-on-september-17th"
  },
  "original_language": "en",
  "account": null,
  "summary": "VANCOUVER, Wash., Sept. 15, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic colorectal cancer (mCRC) and triple-negative breast cancer (TNBC), today announced…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Altrova Health to Present at the Life Sciences Investor Forum on September 17th",
        "url": "https://urgent.news/2026/09/15/altrova-health-to-present-at-the-life-sciences-investor-forum-on",
        "published": "2026-09-15T11:17:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}